This is a Validated Antibody Database (VAD) review about human AMACR, based on 15 published articles (read how Labome selects the articles), using AMACR antibody in all methods. It is aimed to help Labome visitors find the most suited AMACR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
AMACR synonym: AMACRD; CBAS4; P504S; RACE; alpha-methylacyl-CoA racemase; 2-methylacyl-CoA racemase

Santa Cruz Biotechnology
mouse monoclonal (2A10F3)
  • immunohistochemistry; human; 1:500; fig 2
Santa Cruz Biotechnology AMACR antibody (santa Cruz, sc-81710) was used in immunohistochemistry on human samples at 1:500 (fig 2). Oncol Lett (2016) ncbi
mouse monoclonal (2A10F3)
  • immunohistochemistry - paraffin section; human; fig 2
Santa Cruz Biotechnology AMACR antibody (santa Cruz, sc-81710) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2015) ncbi
Invitrogen
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to study the use of AMACR expression in the diagnosis of malignant pleural mesothelioma, Invitrogen AMACR antibody (Thermo Scientific, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Turk J Med Sci (2015) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2a
In order to study the use of AMACR expression for the prognosis of adenocarcinoma and squamous cell carcinoma of lung, Invitrogen AMACR antibody (Thermo Scientific, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2a). Acta Chir Belg (2013) ncbi
Dako
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; tbl s18
Dako AMACR antibody (Dako, M3616) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl s18). Science (2017) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1d
Dako AMACR antibody (Dako, M3616) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1d). Oncol Lett (2016) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:200; fig st2
Dako AMACR antibody (Dako, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig st2). Oncotarget (2016) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry; human; 1:100
Dako AMACR antibody (Dako, 13H4) was used in immunohistochemistry on human samples at 1:100. Urol Oncol (2015) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:100
Dako AMACR antibody (Dako, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Imaging (2015) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:100
Dako AMACR antibody (Dako, M3616) was used in immunohistochemistry - paraffin section on human samples at 1:100. Virchows Arch (2014) ncbi
BioLogo
rabbit monoclonal (13H4)
  • immunohistochemistry - free floating section; human; fig 1
BioLogo AMACR antibody (Biologo, 13H4) was used in immunohistochemistry - free floating section on human samples (fig 1). Prostate (2016) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry; human; 1:200
BioLogo AMACR antibody (Biologo, 13H4) was used in immunohistochemistry on human samples at 1:200. Virchows Arch (2011) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:100
BioLogo AMACR antibody (BioLogo, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2011) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:200
BioLogo AMACR antibody (Biologo, 13H4) was used in immunohistochemistry - paraffin section on human samples at 1:200. Virchows Arch (2008) ncbi
rabbit monoclonal (13H4)
  • immunohistochemistry - paraffin section; human; 1:25
BioLogo AMACR antibody (Biologo, P504S) was used in immunohistochemistry - paraffin section on human samples at 1:25. Pathology (2006) ncbi
Articles Reviewed
  1. Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357: pubmed publisher
  2. Sui X, Hu Y, Zhang C, Pan H, Li D. Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncol Lett. 2016;12:1074-1078 pubmed
  3. Ji C, Zhou M, Gan W, Zheng J, Yan X, Guo H. Advanced prostatic ductal carcinoma in a patient with a long survival time following a total pelvis exenteration: A case report. Oncol Lett. 2016;11:1509-1511 pubmed
  4. Meller S, Meyer H, Bethan B, Dietrich D, Maldonado S, Lein M, et al. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer. Oncotarget. 2016;7:1421-38 pubmed publisher
  5. Bonkhoff H. Significance of prostate cancer missed on needle biopsy tools for retrieving missed cancer. Prostate. 2016;76:369-75 pubmed publisher
  6. Tsutsumi Y, Nomiyama T, Kawanami T, Hamaguchi Y, Terawaki Y, Tanaka T, et al. Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth. PLoS ONE. 2015;10:e0139709 pubmed publisher
  7. Duyar S, Yilmaz A, Demirag F, ErdoÄŸan Y, Yazici Ã, Karakaya J. The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/ P504S) as an immunohistochemical marker in malign pleural mesothelioma. Turk J Med Sci. 2015;45:607-14 pubmed
  8. Suryavanshi M, Mehta A, Jaipuria J, Sharma A, Rawal S, Seth N. Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook. Urol Oncol. 2015;33:331.e9-15 pubmed publisher
  9. Gibbs S, Genega E, Salemi J, Kianzad V, Goodwill H, Xie Y, et al. Near-infrared fluorescent digital pathology for the automation of disease diagnosis and biomarker assessment. Mol Imaging. 2015;14: pubmed publisher
  10. Seipel A, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465:559-65 pubmed publisher
  11. Erdogan Y, Demirag F, Duyar S, Yilmaz A, Yazici U, Aydogdu K. Clinical significance of the expression of alpha-methylacyl-CoA racemase in squamous cell carcinoma and adenocarcinoma of the lung. Acta Chir Belg. 2013;113:263-9 pubmed
  12. Noske A, Zimmermann A, Caduff R, Varga Z, Fink D, Moch H, et al. Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Arch. 2011;459:91-7 pubmed publisher
  13. Hailemariam S, Vosbeck J, Cathomas G, Zlobec I, Mattarelli G, Eichenberger T, et al. Can molecular markers stratify the diagnostic value of high-grade prostatic intraepithelial neoplasia?. Hum Pathol. 2011;42:702-9 pubmed publisher
  14. Gunia S, May M, Scholmann K, Störkel S, Hoschke B, Koch S, et al. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Arch. 2008;453:165-70 pubmed publisher
  15. Went P, Sauter G, Oberholzer M, Bubendorf L. Abundant expression of AMACR in many distinct tumour types. Pathology. 2006;38:426-32 pubmed